Maverick Simulation Solutions Limited Unlisted Share Price Today

2120 +0 (0%) 1Y
Price per Unit 2120
Minimum no. of Units 12
Enter Units
Investment Amount 0
Stamp Duty (0.015 %) 0
Final Amount 0
Unlisted shares

Maverick Simulation Solutions Limited Unlisted Shares

DRHP Status : Not Filed

Trending

2120

Fundamentals About Maverick Simulation Solutions Limited

Current Price 2120
Market Cap 1106 Cr
ISIN INE1BEQ01014
Face Value 10
P/E Ratio 55.28
EPS 0.22
P/B Ratio 20.19
Book Value 111.42
Debt to Equity Ratio 0.31

Downloads & Investor Documents

All documents are provided for informational purposes and are subject to regulatory disclosures.

Key Financials of Maverick Simulation Solutions Limited

P&L Statement 2024
Revenue 70.5
Cost of Material Consumed 48.2
Change in Inventory -7.2
Gross Margins 41.84
Employee Benefit Expenses 1.1
Other Expenses 1.7
EBITDA 26.7
OPM 37.87
Other Income 0.22
Finance Cost 0.14
D&A 0.02
EBIT 26.68
EBIT Margins 37.84
PBT 26.7
PBT Margins 37.87
Tax 6.7
PAT 20
NPM 28.37
EPS 42.11
Financial Ratios
2024
Operating Profit Margin 37.87
Net Profit Margin 28.37
Earning Per Share (Diluted) 42.11
Assets 2024
Fixed Assets 0.47
CWIP 0
Investments 0
Trade Receivables 71.5
Inventory 7.3
Other Assets 26.73
Total Assets 106
Liabilities 2024
Share Capital 4.75
FV 10
Reserves 40
Borrowings 14
Trade Payables 27
Other Liabilities 20.25
Total Liabilities 106
documents

About Company

Maverick Simulation Solutions Limited, based in New Delhi and established as a leader in medical simulation, designs, manufactures, and supplies high-fidelity, "Made-in-India" simulators for healthcare training. Founded by Anuj Chahal in 2006, the company pivoted to medtech in 2019, providing advanced, AI/VR-enabled tools for medical institutions to enhance skills and patient safety

The following table shows a 10-point analysis of Maverick Simulation Solutions Limited. We will discuss each point in detail after this table.

Parameter Key Numbers Insights
Business Overview Incorporated 2019 (medical domain) A simulation technology company focused on healthcare training solutions.
Industry MedTech · Simulation Technology Operates in the medical education and training infrastructure.
Core Products Medical simulators · training systems Offers task trainers, high-fidelity simulators, and virtual labs.
Client Base 100+ institutions Includes medical colleges, hospitals, and institutions.
Revenue ₹136.3 Cr (FY25) Strong growth from ₹14.2 Cr in FY24.
Profitability ₹47.8 Cr PAT (FY25) Significant improvement in margins.
EBITDA Strong margin expansion Driven by scale and product mix.
Debt Position Low leverage (0.24x) Comfortable balance sheet.
Business Model Product + turnkey solutions Revenue from equipment and simulation lab setups.
Outlook High-growth medtech segment Driven by digital healthcare education demand.

 

Company Overview

(i) Maverick Simulation Solutions Limited is a medical simulation technology company that develops advanced training systems for healthcare education and clinical skill development. 

(ii) The company offers a wide range of simulation products, including task trainers, full-body patient simulators, and virtual anatomy systems, used for training medical students and professionals.

(iii) It provides end-to-end solutions such as simulation labs, digital anatomy platforms, and turnkey training infrastructure, enabling institutions to adopt modern learning methods. 

(iv) Maverick serves 100+ institutions, including AIIMS, IITs, and other medical colleges, reflecting strong institutional adoption. 

(v) The company is focused on innovation, with a planned ₹50 crore investment in R&D to integrate AI, AR, and VR into medical training solutions. 

Challenges in Maverick Simulation Solutions Limited’s Business

  • High working capital requirements: Growth has led to increased receivables, impacting operating cash flows. 
  • Technology and R&D dependency: Continuous investment is required to stay relevant in evolving simulation technologies.
  • Client concentration risk: Dependence on institutional clients such as colleges and hospitals.
  • Adoption risk in emerging markets: Simulation-based learning adoption is still evolving in India.

Financial Review of Maverick Simulation Solutions Limited

Here are some highlights of the financial performance of Maverick Simulation Solutions Limited over the past few years.

FY25 Performance

• Revenue from operations stood at ₹136.30 crore
• Profit before tax stood at ₹61.30 crore
• Profit after tax reported at ₹47.82 crore
• Net profit margin expanded to 35%

FY24 Performance

• Revenue from operations stood at ₹14.22 crore
• Profit before tax stood at ₹1.26 crore
• Profit after tax reported at ₹0.94 crore
• Margins remained modest due to the early growth stage 

FY23 Performance

• Revenue base was early-stage and limited scale
• Profitability remained low due to the expansion phase
• Investments focused on product development and scaling
• Business was in the initial commercialisation phase

Quick Summary

Maverick Simulation Solutions Limited is a high-growth medtech company operating in the healthcare simulation space. The company has demonstrated a sharp financial turnaround in FY25, with strong revenue growth and margin expansion. With increasing adoption of simulation-based learning and continued investment in R&D, the company holds strong long-term growth potential, though working capital and technology risks remain key factors.

Click Here to visit the official website of Maverick Simulation Solutions Limited.

Promoters of Maverick Simulation Solutions Limited

The following are the active promoters/leadership associated with the company:

Name Designation LinkedIn Profile
Anuj Chahal Founder & CEO View Profile
Dr. Sunil Tomar Director -

 

Shareholding Pattern of Maverick Simulation Solutions Limited

Name Holding
Promoters 82.74%
Other 17.26%

Promoters of Maverick Simulation Solutions Limited

Name Designation Experience Linkedin Profile
Anuj Chahal Founder & CEO 20+ unlisted-linkedin
Dr. Sunil Tomar Director 20+ unlisted-linkedin

Latest News

Latest Post

Coming soon...

Coming soon...

Latest news display here

Frequently Asked Questions

Maverick Simulation Solutions Limited unlisted shares are equity shares of the company that are not listed on NSE or BSE and are traded privately.

Yes, Maverick Simulation Solutions Limited unlisted shares can be purchased through private market platforms, subject to availability.

Yes, a demat account is required to hold Maverick Simulation Solutions Limited unlisted shares.

The company operates in a high-growth medtech segment with great financial improvement, but like all unlisted investments, it carries liquidity and execution risks.

Yes, Maverick Simulation Solutions Limited unlisted shares can be sold in the secondary market depending on demand and availability.

Yes, as per SEBI regulations, pre-IPO investors are subject to a six-month lock-in period after listing.

If held for more than two years, gains are taxed at 20% with indexation; otherwise, taxed as per the income slab.

Scroll Top ↑
unlistedkraft
Contact Us